Surgical outcomes of ipsilateral metachronous second primary lung cancer

被引:6
|
作者
Sato, Seijiro [1 ]
Shimizu, Yuki [1 ]
Goto, Tatsuya [1 ]
Koike, Terumoto [1 ]
Koizumi, Takahisa [2 ]
Watanabe, Takehiro [2 ]
Shinohara, Hirohiko [3 ]
Yamato, Yasushi [3 ]
Tsuchida, Masanori [1 ]
机构
[1] Niigata Univ, Div Thorac & Cardiovasc Surg, Grad Sch Med & Dent Sci, Niigata, Japan
[2] Natl Hosp Org Nishi Niigata Chuo Hosp, Dept Thorac Surg, Niigata, Japan
[3] Nagaoka Red Cross Hosp, Div Gen Thorac Surg, Niigata, Japan
关键词
Ipsilateral metachronous second primary lung cancer; Ipsilateral second surgery; Wedge resection; Anatomic resection; Postoperative complications; RESECTION; STAGE; LOBECTOMY; SURVIVAL;
D O I
10.1093/icvts/ivab025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: The optimal surgical approach for metachronous second primary lung cancer (MSPLC), especially ipsilateral MSPLC, remains unclear. This study aimed to review postoperative complications and examine surgical outcomes based on the extent of resection after surgery for ipsilateral MSPLC. METHODS: Clinical data from 61 consecutive patients who underwent pulmonary resection for ipsilateral MSPLC according to the Martini-Melamed criteria between January 2005 and December 2017 in 3 institutes were retrospectively reviewed. RESULTS: Postoperative complications were identified in 12 patients (19.7%). Regarding the combination of initial and second surgery, intraoperative bleeding was significantly greater in patients with anatomic-anatomic resection than in others (P < 0.001). Operation time was significantly longer in patients with anatomic-anatomic resection than in others (P <0.001). However, postoperative complications showed no significant differences based on the combination of surgeries. Five-year overall survival rates in patients with anatomic resection and wedge resection after second surgery were 75.8% and 75.8%, respectively (P= 0.738), and 5-year recurrence-free survival rates were 54.2% and 67.6%, respectively (P = 0.368). Cox multivariate analysis identified ever-smoker status (P = 0.029), poor performance status (P = 0.011) and tumour size >20 mm (P = 0.001) as independent predictors of poor overall survival, while ever-smoker status (P = 0.040) and tumour size >20 mm (P = 0.007) were considered independent predictors of poor recurrence-free survival. CONCLUSIONS: Regarding postoperative and long-term outcomes for patients with ipsilateral MSPLC, surgical intervention is safe and offers good long-term survival. Wedge resection is an acceptable provided tumours <= 2 cm and ground-glass opacity-predominant as a second surgery for early-stage ipsilateral MSPLC.
引用
收藏
页码:896 / 903
页数:8
相关论文
共 50 条
  • [1] Surgical Treatment of Metachronous Second Primary Lung Cancer
    Yang, Jie
    Liu, Ming
    Fan, Jie
    Song, Nan
    He, Wen-xin
    Yang, Yu-ling
    Xia, Yan
    Jiang, Ge-ning
    ANNALS OF THORACIC SURGERY, 2014, 98 (04): : 1192 - 1198
  • [2] Surgical Treatment for Metachronous Second Primary Lung Cancer after Radical Resection of Primary Lung Cancer
    Ishigaki, Takahiko
    Yoshimasu, Tatsuya
    Oura, Shoji
    Ota, Fuminori
    Nakamura, Rie
    Hirai, Yoshimitu
    Okamura, Yoshitaka
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 19 (05) : 341 - 344
  • [3] Commentary: Second ipsilateral metachronous lung cancer: What to do?
    D'Andrilli, Antonio
    Rendina, Erino A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (05): : 1400 - 1401
  • [4] METACHRONOUS, IPSILATERAL PRIMARY NEOPLASMS OF THE LUNG
    SHANKER, PS
    SCOTT, JH
    ANDERSON, CL
    CA-A CANCER JOURNAL FOR CLINICIANS, 1980, 30 (05) : 302 - 304
  • [5] Survival in Patients with Metachronous Second Primary Lung Cancer
    Duc Ha
    Choi, Humberto
    Chevalier, Cory
    Zell, Katrina
    Wang, Xiao-Feng
    Mazzone, Peter J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (01) : 79 - 84
  • [6] Survival In Patients With Metachronous Second Primary Lung Cancer
    Ha, D.
    Choi, H.
    Chevalier, C.
    Mazzone, P. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Outcomes of Surgery for Metachronous Second Primary Non-small Cell Lung Cancer
    Soro-Garcia, Jose
    Ramos, Angel Cilleruelo
    Fuentes-Martin, Alvaro
    Bellino, Mauricio Alfredo Loucel
    Puentes, David Alfonso Mora
    Soriano, Genesis Isabel Victoriano
    Gonzalez, Jose Maria Matilla
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (11): : 743 - 749
  • [8] Clinical outcomes of patients with metachronous second primary lung adenocarcinomas
    Zhao, Heng
    Yang, Haitang
    Han, Ke
    Xu, Jianlin
    Yao, Feng
    Zhao, Yang
    Fan, Liwen
    Gu, Haiyong
    Shen, Zhenya
    ONCOTARGETS AND THERAPY, 2017, 10 : 295 - 302
  • [9] Prognostic Factors and Strategies for Metachronous Second Primary Lung Cancer
    Shimizu, D.
    Kataoka, M.
    Okutani, D.
    Watanabe, K.
    Kawai, H.
    Harita, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S276 - S276
  • [10] Surgical outcomes of second primary lung cancer after the extrapulmonary malignancy
    Ko, Kai-Hsiung
    Huang, Hsu-Kai
    Chen, Yi-, I
    Chang, Hung
    Tsai, Wu-Chuan
    Huang, Tsai-Wang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (12) : 3323 - 3332